Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 2,849Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2Dr. Reddy's Laboratories

02 2Accure Labs

03 1Apotex Inc

04 1Assia Chemical Industries Ltd

05 2Bluepharma

06 2Intas Pharmaceuticals

07 2Laboratorio Eczane Pharma

08 12Novartis Pharmaceuticals Australia Pty Limited

09 5Novartis Pharmaceuticals Corporation

10 2Novartis South Africa (Pty) Ltd

11 1Novugen

12 1Pharmacare Premium

13 1Pharmascience Inc.

14 2Pluviaendo

15 2Sakar Healthcare

16 1Sun Pharmaceutical Industries Limited

17 2TherDose Pharma

18 2Torrent Pharmaceuticals Limited

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Regulatory Info : Lead Market Dossiers- Under Development

Registration Country : India

Pazopanib Hydrochloride

Brand Name :

Dosage Form : Oral Solid Dosage Form

Dosage Strength : 200MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Lead Market Dossiers- Under Development

Registration Country : India

Dr Reddy Company Banner

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Regulatory Info : Lead Market Dossiers- Under Development

Registration Country : India

Pazopanib Hydrochloride

Brand Name :

Dosage Form : Oral Solid Dosage Form

Dosage Strength : 400MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Lead Market Dossiers- Under Development

Registration Country : India

Dr Reddy Company Banner

03

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Pazopanib

Brand Name :

Dosage Form : TABLET

Dosage Strength : 200MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : India

blank

04

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Pazopanib

Brand Name :

Dosage Form : TABLET

Dosage Strength : 400MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : India

blank

05

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

PAZOPANIB HYDROCHLORIDE

Brand Name : PAZOPANIB HYDROCHLORIDE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 200MG BASE

Packaging :

Approval Date : 2023-10-19

Application Number : 217713

Regulatory Info : RX

Registration Country : USA

blank

06

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

PAZOPANIB HYDROCHLORIDE

Brand Name : PAZOPANIB HYDROCHLORIDE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 200MG BASE

Packaging :

Approval Date : 2023-10-19

Application Number : 217517

Regulatory Info : RX

Registration Country : USA

blank

07

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

PAZOPANIB HYDROCHLORIDE

Brand Name :

Dosage Form : Film Coated Tablet

Dosage Strength : 200MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Portugal

blank

08

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

PAZOPANIB HYDROCHLORIDE

Brand Name :

Dosage Form : Film Coated Tablet

Dosage Strength : 400MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Portugal

blank

09

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Pazopanib Hydrochloride

Brand Name :

Dosage Form : Film Coated Tablet

Dosage Strength : 200MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

10

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Pazopanib Hydrochloride

Brand Name :

Dosage Form : Film Coated Tablet

Dosage Strength : 400MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

11

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Pazopanib Hydrochloride

Brand Name : Pazopane

Dosage Form : Tablet

Dosage Strength : 200MG

Packaging : 30 Tabs

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Argentina

blank

12

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Pazopanib Hydrochloride

Brand Name : Pazopane

Dosage Form : Tablet

Dosage Strength : 400MG

Packaging : 30 Tabs

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Argentina

blank

13

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

PAZOPANIB HYDROCHLORIDE

Brand Name : VOTRIENT

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 200MG BASE

Packaging :

Approval Date : 2009-10-19

Application Number : 22465

Regulatory Info : RX

Registration Country : USA

blank

14

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

PAZOPANIB HYDROCHLORIDE

Brand Name : VOTRIENT

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 400MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 2009-10-19

Application Number : 22465

Regulatory Info : DISCN

Registration Country : USA

blank

15

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

PAZOPANIB HYDROCHLORIDE

Brand Name : PAZOPANIB HYDROCHLORIDE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 200MG BASE

Packaging :

Approval Date : 2024-04-23

Application Number : 218231

Regulatory Info : RX

Registration Country : USA

blank

16

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Pazopanib Hydrochloride

Brand Name :

Dosage Form :

Dosage Strength :

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Malta

blank

17

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

PAZOPANIB HYDROCHLORIDE

Brand Name : PAZOPANIB HYDROCHLORIDE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 200MG BASE

Packaging :

Approval Date : 2023-10-19

Application Number : 215837

Regulatory Info : RX

Registration Country : USA

blank

18

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Pazopanib Hydrochloride

Brand Name :

Dosage Form : Tablets

Dosage Strength : 200mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

19

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Pazopanib Hydrochloride

Brand Name :

Dosage Form : Tablet

Dosage Strength : 200MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

20

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Pazopanib Hydrochloride

Brand Name :

Dosage Form : Tablet

Dosage Strength : 400MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank